Logo image of BHAT

BLUE HAT INTERACTIVE ENTERTA (BHAT) Stock Fundamental Analysis

NASDAQ:BHAT - Nasdaq - KYG1329V1142 - Common Stock - Currency: USD

1.72  -0.13 (-7.03%)

Fundamental Rating

1

Taking everything into account, BHAT scores 1 out of 10 in our fundamental rating. BHAT was compared to 72 industry peers in the Entertainment industry. Both the profitability and financial health of BHAT have multiple concerns. BHAT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BHAT had negative earnings in the past year.
BHAT had a negative operating cash flow in the past year.
BHAT had negative earnings in 4 of the past 5 years.
BHAT had negative operating cash flow in 4 of the past 5 years.
BHAT Yearly Net Income VS EBIT VS OCF VS FCFBHAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

BHAT has a worse Return On Assets (-12.69%) than 70.83% of its industry peers.
BHAT has a Return On Equity of -29.75%. This is comparable to the rest of the industry: BHAT outperforms 43.06% of its industry peers.
Industry RankSector Rank
ROA -12.69%
ROE -29.75%
ROIC N/A
ROA(3y)-26.27%
ROA(5y)-44.9%
ROE(3y)-51.16%
ROE(5y)-103.15%
ROIC(3y)N/A
ROIC(5y)N/A
BHAT Yearly ROA, ROE, ROICBHAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

BHAT has a worse Gross Margin (10.53%) than 79.17% of its industry peers.
In the last couple of years the Gross Margin of BHAT has declined.
BHAT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.32%
GM growth 5Y-31.22%
BHAT Yearly Profit, Operating, Gross MarginsBHAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

3

2. Health

2.1 Basic Checks

BHAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BHAT has about the same amount of shares outstanding.
The number of shares outstanding for BHAT has been increased compared to 5 years ago.
BHAT has a better debt/assets ratio than last year.
BHAT Yearly Shares OutstandingBHAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K 500K
BHAT Yearly Total Debt VS Total AssetsBHAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.49, we must say that BHAT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BHAT (-0.49) is worse than 70.83% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that BHAT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, BHAT is in the better half of the industry, outperforming 73.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.49
ROIC/WACCN/A
WACC8.64%
BHAT Yearly LT Debt VS Equity VS FCFBHAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

BHAT has a Current Ratio of 1.71. This is a normal value and indicates that BHAT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.71, BHAT is doing good in the industry, outperforming 73.61% of the companies in the same industry.
BHAT has a Quick Ratio of 1.71. This is a bad value and indicates that BHAT is not financially healthy enough and could expect problems in meeting its short term obligations.
BHAT's Quick ratio of 0.12 is on the low side compared to the rest of the industry. BHAT is outperformed by 90.28% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.12
BHAT Yearly Current Assets VS Current LiabilitesBHAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

3. Growth

3.1 Past

BHAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.55%, which is quite impressive.
Looking at the last year, BHAT shows a very negative growth in Revenue. The Revenue has decreased by -74.32% in the last year.
The Revenue has been decreasing by -4.43% on average over the past years.
EPS 1Y (TTM)74.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.58%
Revenue 1Y (TTM)-74.32%
Revenue growth 3Y7.82%
Revenue growth 5Y-4.43%
Sales Q2Q%-79.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHAT Yearly Revenue VS EstimatesBHAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHAT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHAT Price Earnings VS Forward Price EarningsBHAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHAT Per share dataBHAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BHAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE HAT INTERACTIVE ENTERTA

NASDAQ:BHAT (7/15/2025, 3:04:23 PM)

1.72

-0.13 (-7.03%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)04-30 2025-04-30
Earnings (Next)N/A N/A
Inst Owners0.57%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap12.45M
Analysts0
Price TargetN/A
Short Float %2.33%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-16.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS2.62
BVpS4.42
TBVpS4.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.69%
ROE -29.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.53%
FCFM N/A
ROA(3y)-26.27%
ROA(5y)-44.9%
ROE(3y)-51.16%
ROE(5y)-103.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.32%
GM growth 5Y-31.22%
F-Score4
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 0.12
Altman-Z -0.49
F-Score4
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-74.32%
Revenue growth 3Y7.82%
Revenue growth 5Y-4.43%
Sales Q2Q%-79.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.29%
OCF growth 3YN/A
OCF growth 5YN/A